Published in Women's Health Weekly, March 9th, 2006
The research at UHC will focus on clinical applications developed at UHC for the identification and treatment of certain gynecological disorders including cervical dysplasia and cervical cancer. These include patented technology developed out of the clinical practice of Dr. George Gorodeski and McDonald Physician's practice group of UHC.
CytoCore's CEO, David Weissberg, MD, said: "This new agreement with University Hospitals of Cleveland and its Center for Clinical Research is...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly